Your browser doesn't support javascript.
loading
Experimental microbial dysbiosis does not promote disease progression in SIV-infected macaques.
Ortiz, Alexandra M; Flynn, Jacob K; DiNapoli, Sarah R; Vujkovic-Cvijin, Ivan; Starke, Carly E; Lai, Stephen H; Long, MacKenzie E; Sortino, Ornella; Vinton, Carol L; Mudd, Joseph C; Johnston, Leslie; Busman-Sahay, Kathleen; Belkaid, Yasmine; Estes, Jacob D; Brenchley, Jason M.
Afiliação
  • Ortiz AM; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Flynn JK; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • DiNapoli SR; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Vujkovic-Cvijin I; Mucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD, USA.
  • Starke CE; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Lai SH; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Long ME; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Sortino O; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Vinton CL; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Mudd JC; Barrier Immunity Section, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
  • Johnston L; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA.
  • Busman-Sahay K; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, USA.
  • Belkaid Y; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR, USA.
  • Estes JD; Mucosal Immunology Section, Laboratory of Parasitic Diseases, NIAID, NIH, Bethesda, MD, USA.
  • Brenchley JM; NIAID Microbiome Program, NIH, Bethesda, MD, USA.
Nat Med ; 24(9): 1313-1316, 2018 09.
Article em En | MEDLINE | ID: mdl-30061696
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Imunodeficiência Adquirida dos Símios / Vírus da Imunodeficiência Símia / Progressão da Doença / Disbiose Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Imunodeficiência Adquirida dos Símios / Vírus da Imunodeficiência Símia / Progressão da Doença / Disbiose Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article